Effect of nedocromil sodium on down-regulation of pulmonary beta-adrenoceptors

Clin Sci (Lond). 1989 Jun;76(6):599-602. doi: 10.1042/cs0760599.

Abstract

1. We have studied the effect of the anti-inflammatory anti-asthma drug, nedocromil sodium, on down-regulation of pulmonary beta-adrenoceptors in guinea-pig lung. 2. Incubation of minced lung with isoprenaline (10 mumol/l) resulted in a reduction in maximum binding capacity of [125I]iodocyanopindolol to lung membranes from 246 +/- 4 to 169 +/- 6 fmol/mg of protein (mean +/- SEM, P less than 0.01, n = 18). 3. Nedocromil sodium, which had no direct effect on [125I]iodocyanopindolol binding, prevented isoprenaline-induced down-regulation, giving complete protection at a dose of 100 mumol/l. 4. The mechanism of this effect is not certain, but nedocromil sodium may interfere with the internalization of beta-adrenoceptors in pulmonary parenchymal cells. This may have some therapeutic relevance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Guinea Pigs
  • Iodocyanopindolol
  • Isoproterenol / pharmacology*
  • Lung / drug effects*
  • Lung / metabolism
  • Male
  • Membranes / drug effects
  • Membranes / metabolism
  • Nedocromil
  • Pindolol / analogs & derivatives*
  • Pindolol / metabolism
  • Quinolones / pharmacology*
  • Receptors, Adrenergic, beta / drug effects*
  • Receptors, Adrenergic, beta / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Quinolones
  • Receptors, Adrenergic, beta
  • Nedocromil
  • Iodocyanopindolol
  • Pindolol
  • Isoproterenol